#FSP Alums @HollyLynchez and @SteveJoffe w/ @MadisonKilbride write in @PhillyInquirer, "Drugs should be approved for over-the-counter (OTC) use unless the FDA determines they can’t be taken safely without a prescription." https://t.co/pX7UPu3DSE
Two recent news stories, about hormonal contraceptives and naloxone, align with what @MadisonKilbride, @SteveJoffe, and I recently argued in @hastingscenter: FDA should allow more drugs to be marketed over-the-counter.
https://t.co/1BFLJXCSw4
This excellent paper by @MadisonKilbride, @SteveJoffe, and @HollyLynchez convincingly argues that many drugs that currently require a prescription should be available over the counter (e.g., oral contraception and inhalers). https://t.co/lIoiQ5DOTO
#ELSI scholarship is constantly evolving as new technologies raise new ethical questions. @ELSIhub recently spoke with three ELSI scholars, @MadisonKilbride, @stephakraft, & R. Brian Woodbury about their experiences and where they are now in their careers. https://t.co/igWV1djS28
Want to read a paper that doesn't mention COVID once? @MadisonKilbride@SteveJoffe and I have a new article out in The Hastings Center Report - "Prescription Requirements and Patient Autonomy: Considering an Over‐the‐Counter Default"
https://t.co/zkG4teYcR8
.@MadisonKilbride addresses an issue that has been underexplored in the medical ethics literature: the lack of insurance coverage for IVF-with-preimplantation genetic testing.https://t.co/TilJiRJbuj
.@MadisonKilbride in @GIMJournal: "Telephone disclosure of genetic test results is a reasonable alternative to in-person disclosure, but attention to medical follow-up may remain important for optimizing appropriate use of genetic results. https://t.co/qaZqbGUUen
Our #T32 fellow, Dr. @MadisonKilbride, presents her paper: "The Use of Company-provided Physicians in Direct-to-consumer Genetic Testing: A Violation of Ethical and Professional Standards?" Check it out in the @2020_iab app & on the website. #IAB2020#WCB2020#Bioethics
Delighted to see my new Review Article on DTC genetic testing for cancer susceptibility, co-authored with Angela Bradbury, out in JCO Precision Oncology @ASCO_pubs. https://t.co/mWXdhrFVm4
Excited about my new Viewpoint with Angela Bradbury out in @JAMA_current, "The Need to Improve the Clinical Utility of Direct-to-Consumer Genetic Tests: Either Too Narrow or Too Broad." https://t.co/KYxHXFlnLq